T

    Twist Bioscience Corp (TWST)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NASDAQ

    $139.00
    -2.38 (-1.68%)

    Market Cap: $8.87B

    Last updated: Sep 01, 2026 at 10:00 AM ET

    Earnings

    Performance (10Y)

    Beat Rate
    66%(21/32)
    Avg Surprise
    -21.54%

    Upcoming Estimates

    Sep 30, 2026
    EPS Consensus$0.63
    Range$0.60 - $0.66
    2 analysts
    Revenue Consensus
    $132M
    Range$132M - $132M
    9 analysts
    Dec 31, 2026
    EPS Consensus$-0.05
    Range$-0.06 - $-0.04
    2 analysts
    EPS Revisions
    1
    0
    7d
    1
    1
    30d
    EPS Estimate Drift
    90d ago$0.00+100.0%
    60d ago$0.00+100.0%
    30d ago$-0.10-90.0%
    7d ago$-0.10-90.0%
    Current$-0.05
    Revenue Consensus
    $126M
    Range$122M - $128M
    7 analysts
    PeriodReportedEst.SurpriseB/MYoY
    Dec 26EST
    		-$-0.05---
    Sep 26EST
    		-$0.63---
    Jun 26
    		$-0.56$-0.50-12.00%Miss-19.1%
    Mar 26
    		$-0.60$-0.53-13.21%Miss+9.1%
    Dec 25
    		$-0.50$-0.52+3.85%Beat+5.7%
    Sep 25
    		$-0.45$-0.50+10.00%Beat+23.7%
    Jun 25
    		$-0.47$-0.57+17.54%Beat+32.9%
    Mar 25
    		$-0.66$-0.56-17.86%Miss+16.5%
    Dec 24
    		$-0.53$-0.63+15.87%Beat+29.3%
    Sep 24
    		$-0.59$-0.69+14.49%Beat+21.3%
    Jun 24
    		$-0.70$-0.77+9.09%Beat+31.4%
    Mar 24
    		$-0.79$-0.81+2.47%Beat+25.5%
    Dec 23
    		$-0.75$-0.77+2.60%Beat+7.4%
    Sep 23
    		$-0.75$-0.86+12.79%Beat+25.7%
    Jun 23
    		$-1.02$-1.06+3.77%Beat+5.6%
    Mar 23
    		$-1.06$-1.10+3.64%Beat-3.9%
    Dec 22
    		$-0.81$-1.17+30.77%Beat+15.6%
    Sep 22
    		$-1.01$-1.13+10.62%Beat-20.2%
    Jun 22
    		$-1.08$-1.31+17.56%Beat-38.5%
    Mar 22
    		$-1.02$-1.30+21.54%Beat-30.8%
    Dec 21
    		$-0.96$-1.06+9.43%Beat-33.3%
    Sep 21
    		$-0.84$-0.79-6.33%Miss-55.6%
    Jun 21
    		$-0.78$-0.75-4.00%Miss-16.4%
    Mar 21
    		$-0.78$-0.78+0.00%Beat+8.2%
    Dec 20
    		$-0.72$-0.77+6.49%Beat+28.0%
    Sep 20
    		$-0.54$-0.70+22.86%Beat+43.7%
    Jun 20
    		$-0.67$-0.88+23.86%Beat+27.2%
    Mar 20
    		$-0.85$-0.75-13.33%Miss+8.6%
    Dec 19
    		$-1.00$-0.83-20.48%Miss+15.3%
    Sep 19
    		$-0.96$-0.83-15.66%Miss+85.4%
    Jun 19
    		$-0.92$-0.82-12.20%Miss-39.4%
    Mar 19
    		$-0.93$-0.97+4.12%Beat-
    Dec 18
    		$-1.18$-0.85-38.82%Miss-
    Sep 18
    		$-6.59$-0.75-778.67%Miss-
    Jun 18
    		$-0.66$0.00N/AMiss-

    Key Metrics

    Valuation
    P/E Ratio-65.88EV/EBITDA-35.26x
    Price/FCF-88.40xFCF Yield-1.13%
    Profitability
    Profit Margin-31.70%Operating Margin-30.60%
    ROE-29.60%ROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current Ratio2.67xQuick Ratio2.38x
    Trading Statistics
    Beta2.16Avg Volume1.80M
    52-Week High$155.4452-Week Low$23.30

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$141.62
    SMA 20$129.84
    SMA 50$107.75
    SMA 200$62.75
    EMA 10$140.04
    EMA 20$130.52
    EMA 50$110.88
    EMA 200$72.84

    MACD

    Line: 12.52Signal: 12.22Hist: 0.31

    ADX

    ADX: 44.8+DI: 26.3-DI: 15.2

    Aroon & PSAR

    Aroon Up92.0
    Aroon Down20.0
    PSAR$155.15

    Bollinger Bands

    Upper Band$160.39
    Lower Band$99.29
    %B Position4706%(Upper)
    Band Width0.65

    RSI (14-Day)

    Neutral
    58.9

    Momentum Oscillators

    Stoch %K72.8
    Stoch %D82.6
    Williams %R-40.9
    ROC (10d)11.7%
    Momentum14.59
    CCI (20d)44.9
    MFI (14d)68.5

    Volatility Measures

    ATR (14d)$9.22(6.6%)
    StdDev (20d)15.28
    Hist Vol121.8%(High)

    Volume Flow

    VWAP$138.19
    OBV33.6M
    AD Line28.4M
    CMF (20d)0.220

    Volume Metrics

    Avg Vol (20d)1.7M
    Vol Ratio1.1x
    VWMA (20d)$130.56

    Pivot Points

    R3$161.45
    R2$157.28
    R1$149.33
    Pivot Point$145.16
    S1$137.21
    S2$133.04
    S3$125.09

    Advanced Oscillators

    TSI30.64
    Ultimate Osc57.5
    KST442.80

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$118.38M$110.72M$103.70M$99.01M$96.06M$92.79M$88.71M$84.71M$81.46M$75.30M$71.50M$66.95M
    Cost of Revenue$55.92M$53.59M$49.73M$48.17M$44.76M$46.77M$45.87M$46.48M$46.19M$44.42M$42.54M$42.42M
    Gross Profit$62.45M$57.12M$53.97M$50.84M$51.30M$46.03M$42.84M$38.23M$35.27M$30.88M$28.96M$24.52M
    Operating Expenses$98.73M$102.98M$86.87M$80.77M$81.42M$87.59M$77.48M$74.28M$124.19M$79.77M$75.94M$74.63M
    R&D$18.02M$19.70M$17.13M$17.01M$18.05M$23.92M$21.31M$21.14M$22.47M$24.15M$23.10M$23.75M
    SG&A$80.71M$76.08M$69.74M$63.76M$63.37M$63.67M$56.18M$53.14M$56.79M$55.62M$52.84M$47.39M
    Operating Income$-36,280,000$-45,863,000$-32,900,000$-29,935,000$-30,120,000$-41,560,000$-34,644,000$-36,043,000$-88,922,000$-48,889,000$-46,977,000$-50,111,000
    Interest Income$1.50M$1.71M$2.17M$2.63M$2.69M$2.80M$3.24M$3.62M$3.66M$3.94M$4.12M$3.89M
    Interest Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Income Before Tax$-34,740,000$-43,978,000$-30,254,000$-26,882,000$20.58M$-39,153,000$-31,497,000$-34,751,000$-85,380,000$-45,147,000$-42,888,000$-46,465,000
    Income Tax Expense$311,000$43,000$253,000$256,000$191,000$175,000$97,000$-96,000$191,000$345,000$120,000$-222,000
    Net Income$-35,051,000$-44,021,000$-30,507,000$-27,138,000$20.39M$-39,328,000$-31,594,000$-34,655,000$-85,571,000$-45,492,000$-43,008,000$-46,243,000
    EBITDA$-29,462,000$-39,274,000$-26,235,000$-23,678,000$23.96M$-35,550,000$-28,357,000$-31,715,000$-80,742,000$-40,784,000$-38,837,000$-41,862,000
    EBIT$-36,240,000$-45,688,000$-32,429,000$-29,682,000$17.89M$-41,954,000$-34,737,000$-38,371,000$-89,043,000$-49,088,000$-47,008,000$-50,362,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about TWST

    Government Contracts

    Gov Obligations (TTM)
    $195366
    Gov Obligations / Revenue
    0.0%
    Obligations YoY
    112.9%
    Active Awards
    4
    New Awards (TTM)
    3
    Avg Remaining Term
    10.8 mo

    Top agency: Department of Justice at 47.3% of trailing twelve month obligations across 3 agencies

    Recent Awards

    Award IDAgencyObligatedStart
    15F06726P0000533Department of JusticeFederal Bureau of Investigation$97120Jun 29, 2026
    1232SA25P0166Department of AgricultureAgricultural Research Service$60861Aug 5, 2025
    36C26226P1118Department of Veterans AffairsDepartment of Veterans Affairs$47450Jun 30, 2026

    Federal contract obligations are bookings recorded by the awarding agency, not recognized revenue. They can exceed 100% of revenue and can be negative when contracts are de-obligated. Source: USAspending.gov prime awards, data through Jul 31, 2026.

    News

    Twist Bioscience Corp (TWST) Stock Up 7.5% but GF Value Says Overvalued -- GF Score: 69/100

    Twist Bioscience Corp (TWST) stock rose 7.5% today to $151.42, yet GuruFocus's GF Value™ indicates it is 188.0% overvalued compared to its fair value of $52.58. The company shows strong growth (10/10) but struggles with profitability (3/10) and is considered highly overvalued (1/10). Notably, insiders have sold $64.5M worth of shares over the past year with no buying activity, raising concerns about future prospects.

    GuruFocus•8/25/26•
    Bearish

    Twist Bioscience (NASDAQ: TWST) CFO sells shares to cover taxes

    Twist Bioscience's CFO, Adam Laponis, sold 1,965 shares of common stock at $139.066 per share on August 21, 2026. This transaction was not a discretionary trade but rather a "sell to cover" action to satisfy tax withholding obligations related to the vesting of Restricted Stock Units. Following this sale, Laponis directly holds 108,633 shares of the company's common stock.

    Stock Titan•8/25/26•
    Somewhat-Bearish

    Twist Bioscience (NASDAQ: TWST) COO sells shares in tax-withholding trade

    Twist Bioscience Corp (TWST) President and COO Patrick John Finn sold 4,046 shares of common stock on August 21, 2026, for a total of $563,165. This transaction was a mandatory "sell to cover" to satisfy tax withholding obligations on vested Restricted Stock Units, not a discretionary trade. Following the sale, Finn directly holds 210,802 shares of TWST.

    Stock Titan•8/25/26•
    Neutral

    Twist Bioscience (TWST) HR chief’s share sale is tax-driven

    Twist Bioscience (TWST) HR chief Paula Green sold 1,360 shares of common stock for $139.066 per share on August 21, 2026. This transaction was identified as a mandatory "sell to cover" to satisfy tax withholding obligations on vesting Restricted Stock Units, not a discretionary trade. Following the sale, Green directly holds 117,921 shares of Twist Bioscience.

    Stock Titan•8/25/26•
    Neutral

    Twist Bioscience (TWST) CEO trims stake in tax-driven sale

    Twist Bioscience CEO Emily M. Leproust sold 6,639 shares of common stock on August 21, 2026, for $139.066 per share. This sale was a mandatory "sell to cover" transaction to fulfill tax withholding obligations on vested Restricted Stock Units, not a discretionary trade. Following the sale, Leproust directly holds 812,299 common shares, in addition to various employee stock options.

    Stock Titan•8/25/26•
    Neutral

    Frequently Asked Questions About TWST

    Does TWST pay dividends?
    Twist Bioscience Corp (TWST) does not currently pay a regular dividend.
    What is TWST's market cap?
    Twist Bioscience Corp (TWST) has a market capitalization of $8.87B with a current stock price of $139.00.

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In